← Back to PHAT

Phathom Pharmaceuticals, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 30/07/2026Mar 2026Filed 30/07/2026Sep 2025Filed 30/10/2025Jun 2025Filed 30/07/2026Mar 2025Filed 30/07/2026Sep 2024Filed 30/10/2025Jun 2024Filed 30/10/2025Mar 2024Filed 30/10/2025
$74$58$50$40$29$16$7.3$1.9
−$18−$30−$30−$76−$94−$86−$91−$83
−$0.21−$0.37−$0.41−$1.05−$1.31−$1.32−$1.56−$1.42
8482737272655958

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.